Nuclear Medicine and Molecular Imaging


Kanal geosi va tili: Hindiston, Inglizcha
Toifa: Tibbiyot



Kanal geosi va tili
Hindiston, Inglizcha
Statistika
Postlar filtri














Participants from a low-income or lower middle income country can register for the virtual conference free of cost.














Identification of unknown radionuclides


gaspek_e.pdf
311.8Kb
Sent with Xodo






Based on efficacy results from the phase 3 VISION trial, lutetium Lu 177 vipivotide tetraxetan was approved in the USA on 23 March 2022 for the treatment of adult patients with PSMA-positive metastatic castration-resistant prostate cancer (mCRPC) who have been treated with androgen receptor (AR) pathway inhibition and taxane-based chemotherapy.


Appropriate use criteria in various cancers.



20 ta oxirgi post ko‘rsatilgan.